Xeris Biopharma Holdings, Inc. (XERS) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Xeris Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $3.77 M, a 46.9% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $11.9 M, a 4.34% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.7 M, a 11.9% decline from 2022.
  • Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.2 M, a 6.85% increase from 2021.
  • Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.4 M, a 37.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.9 M $3.77 M +$1.2 M +46.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.7 M $2.77 M +$1 K +0.04% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $10.7 M $2.46 M -$484 K -16.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $11.2 M $2.93 M -$224 K -7.11% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $11.4 M $2.56 M -$737 K -22.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $12.2 M $2.77 M +$23 K +0.84% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $12.1 M $2.94 M -$724 K -19.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $12.9 M $3.15 M +$640 K +25.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $12.2 M $3.3 M +$840 K +34.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11.4 M $2.74 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $3.67 M +$1.61 M +78.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.51 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $2.46 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $2.05 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.